Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 11
2004 9
2005 8
2006 3
2007 2
2009 8
2010 4
2011 4
2012 5
2013 6
2014 5
2015 2
2016 5
2017 2
2018 3
2019 1
2020 2
2021 6
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism.
Vaiman EE, Shnayder NA, Khasanova AK, Strelnik AI, Gayduk AJ, Al-Zamil M, Sapronova MR, Zhukova NG, Smirnova DA, Nasyrova RF. Vaiman EE, et al. Among authors: zhukova ng. Biomedicines. 2022 Aug 18;10(8):2010. doi: 10.3390/biomedicines10082010. Biomedicines. 2022. PMID: 36009557 Free PMC article. Review.
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Ascierto PA, Stroyakovskiy D, Gogas H, Robert C, Lewis K, Protsenko S, Pereira RP, Eigentler T, Rutkowski P, Demidov L, Zhukova N, Schachter J, Yan Y, Caro I, Hertig C, Xue C, Kusters L, McArthur GA, Gutzmer R. Ascierto PA, et al. Among authors: zhukova n. Lancet Oncol. 2023 Jan;24(1):33-44. doi: 10.1016/S1470-2045(22)00687-8. Epub 2022 Nov 29. Lancet Oncol. 2023. PMID: 36460017 Clinical Trial.
Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.
Goncharova PS, Davydova TK, Popova TE, Novitsky MA, Petrova MM, Gavrilyuk OA, Al-Zamil M, Zhukova NG, Nasyrova RF, Shnayder NA. Goncharova PS, et al. Among authors: zhukova ng. Nutrients. 2021 Oct 26;13(11):3804. doi: 10.3390/nu13113804. Nutrients. 2021. PMID: 34836059 Free PMC article. Review.
Reconfigurable monitoring for telecommunication networks.
Tianxing M, Osipov VY, Vodyaho AI, Kalmatskiy A, Zhukova NA, Lebedev SV, Shichkina YA. Tianxing M, et al. Among authors: zhukova na. PeerJ Comput Sci. 2020 Aug 10;6:e288. doi: 10.7717/peerj-cs.288. eCollection 2020. PeerJ Comput Sci. 2020. PMID: 33816939 Free PMC article.
92 results